C07D 215/06
Having only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached to the
Official title: having only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached to the ring nitrogen atom
C07D215/06 (Having only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached to the) appears on 383 US grants and 366 published applications in this corpus.
Search patents in C07D- Granted patents
- 383
- Published applications
- 366
- Assignees
- 296
- Inventors
- 1,368
- Latest grant
- 29 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 6 | 0 |
| 1977 | 6 | 0 |
| 1978 | 3 | 0 |
| 1979 | 2 | 0 |
| 1980 | 4 | 0 |
| 1981 | 3 | 0 |
| 1982 | 3 | 0 |
| 1983 | 4 | 0 |
| 1984 | 4 | 0 |
| 1985 | 6 | 0 |
| 1986 | 2 | 0 |
| 1987 | 4 | 0 |
| 1988 | 7 | 0 |
| 1989 | 9 | 0 |
| 1990 | 7 | 0 |
| 1991 | 6 | 0 |
| 1992 | 4 | 0 |
| 1993 | 5 | 0 |
| 1994 | 2 | 0 |
| 1995 | 5 | 0 |
| 1996 | 2 | 0 |
| 1997 | 9 | 0 |
| 1998 | 3 | 0 |
| 1999 | 3 | 0 |
| 2000 | 4 | 0 |
| 2001 | 3 | 1 |
| 2002 | 7 | 10 |
| 2003 | 5 | 11 |
| 2004 | 7 | 17 |
| 2005 | 5 | 11 |
| 2006 | 11 | 13 |
| 2007 | 9 | 9 |
| 2008 | 4 | 13 |
| 2009 | 9 | 13 |
| 2010 | 6 | 16 |
| 2011 | 8 | 14 |
| 2012 | 11 | 17 |
| 2013 | 6 | 17 |
| 2014 | 17 | 14 |
| 2015 | 19 | 16 |
| 2016 | 15 | 26 |
| 2017 | 14 | 20 |
| 2018 | 21 | 22 |
| 2019 | 14 | 16 |
| 2020 | 14 | 18 |
| 2021 | 20 | 14 |
| 2022 | 11 | 15 |
| 2023 | 6 | 12 |
| 2024 | 9 | 12 |
| 2025 | 11 | 11 |
| 2026 | 8 | 8 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- NAMPT modulators29 Sep 2026US 12,747,203 B2Cytokinetics, Inc.
- Dihydro-cyclopenta-isoquinoline15 Sep 2026US 12,735,396 B2Ucb Biopharma Srl
- Organic electroluminescent element and electronic device using same30 Jun 2026US 12,668,739 B2Idemitsu Kosan Co., Ltd.
- Levorphanol prodrugs and processes for making and using them31 Mar 2026US 12,590,065 B2Zevra Therapeutics, Inc.
- Tetrahydroquinoline derivative and medicinal use thereof10 Mar 2026US 12,570,639 B2Toray Industries, Inc.
- Organic Photoredox Catalysts, Compositions, and Conversion Processes24 Sep 2026US 2026/0284647 A1Colorado State University Research Foundation
- Levorphanol prodrugs and processes for making and using them10 Sep 2026US 2026/0265201 A1Zevra Therapeutics, Inc.
- Deubiquitinase inhibitors and methods of use thereof3 Sep 2026US 2026/0258011 A1
- Process for the manufacturing of (6ar,10ar)-7-propyl-6,6a,7,8,9,10,10a,11-octahydro-[1,3]dioxolo[4',5':5,6]benzo[1,2-g]quinoline and (4ar,10ar)-1-propyl-1,2,3,4,4a,5,10,10a-octahydro-benzo[g]quinoline-6,7-diol23 Jul 2026US 2026/0209181 A1H. Lundbeck A.S.
- Pannexin-1 modulators and methods of treating disorders in which pannexin-1 is implicated28 May 2026US 2026/0146041 A1Pannex Therapeutics Inc.
Most cited
By later US patents
- Compounds having a disubstituted acetylene moiety and retinoic acid-like biological activity158US 5,023,341 AAllergan, Inc. · 1991
- Condensed heterocyclic compounds154US 5,037,825 AHoffmann-La Roche Inc. · 1991
- Ethynyl-chroman compounds138US 5,053,523 AAllergan, Inc. · 1991
- Steroid receptor modulator compounds and methods128US 5,696,127 ALigand Pharmaceuticals Incorporated · 1997
- Steroid receptor modulator compounds and methods120US 5,688,810 ALigand Pharmaceuticals Incorporated · 1997